263 related articles for article (PubMed ID: 21299462)
1. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center.
Machaczka M; Vaktnäs J; Klimkowska M; Hägglund H
Leuk Lymphoma; 2011 Apr; 52(4):613-9. PubMed ID: 21299462
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience.
Lorenz F; Klimkowska M; Pawłowicz E; Bulanda Brustad A; Erlanson M; Machaczka M
Leuk Lymphoma; 2018 Aug; 59(8):1840-1850. PubMed ID: 29295642
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis.
Aulagnon F; Lapidus N; Canet E; Galicier L; Boutboul D; Peraldi MN; Reuter D; Bernard R; Schlemmer B; Azoulay E; Zafrani L
Am J Kidney Dis; 2015 Jun; 65(6):851-9. PubMed ID: 25480521
[TBL] [Abstract][Full Text] [Related]
4. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.
Daver N; McClain K; Allen CE; Parikh SA; Otrock Z; Rojas-Hernandez C; Blechacz B; Wang S; Minkov M; Jordan MB; La Rosée P; Kantarjian HM
Cancer; 2017 Sep; 123(17):3229-3240. PubMed ID: 28621800
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.
Otrock ZK; Eby CS
Am J Hematol; 2015 Mar; 90(3):220-4. PubMed ID: 25469675
[TBL] [Abstract][Full Text] [Related]
6. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival.
Löfstedt A; Jädersten M; Meeths M; Henter JI
Blood; 2024 Jan; 143(3):233-242. PubMed ID: 37595287
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
[TBL] [Abstract][Full Text] [Related]
8. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Tamamyan GN; Kantarjian HM; Ning J; Jain P; Sasaki K; McClain KL; Allen CE; Pierce SA; Cortes JE; Ravandi F; Konopleva MY; Garcia-Manero G; Benton CB; Chihara D; Rytting ME; Wang S; Abdelall W; Konoplev SN; Daver NG
Cancer; 2016 Sep; 122(18):2857-66. PubMed ID: 27244347
[TBL] [Abstract][Full Text] [Related]
9. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic Lymphohistiocytosis and Bone Marrow Hemophagocytosis: A 5-Year Institutional Experience at a Tertiary Care Hospital.
Lao K; Sharma N; Gajra A; Vajpayee N
South Med J; 2016 Oct; 109(10):655-660. PubMed ID: 27706506
[TBL] [Abstract][Full Text] [Related]
11. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study.
Xu XJ; Wang HS; Ju XL; Xiao PF; Xiao Y; Xue HM; Shi HY; Gao YJ; Jia GC; Li XR; Zhao WH; Wang NL; Tang YM;
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781387
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 10 cases of secondary hemophagocytic lymphohistiocytosis treated with HLH-2004 chemotherapy].
Zhang LJ; Qiu HX; Li JY; Xu J; Wang LL; Hu YX; Fan L; Zhang SJ; Xu W; Wu HX; Qian SX; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1525-30. PubMed ID: 21176364
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine.
Daitoku S; Aoyagi T; Takao S; Tada S; Kuroiwa M
Intern Med; 2018 Oct; 57(20):2995-2999. PubMed ID: 29780114
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid malignancy-associated hemophagocytic lymphohistiocytosis: Search for the hidden source.
Bains A; Mamone L; Aneja A; Bromberg M
Ann Diagn Pathol; 2017 Jun; 28():37-42. PubMed ID: 28648938
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
17. Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital.
Karlsson T
Ups J Med Sci; 2015; 120(4):257-62. PubMed ID: 26212358
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience.
Apodaca E; Rodríguez-Rodríguez S; Tuna-Aguilar EJ; Demichelis-Gómez R
Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):e373-e380. PubMed ID: 30037588
[TBL] [Abstract][Full Text] [Related]
19. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic Lymphohistiocytosis in the Elderly.
Altook R; Ruzieh M; Singh A; Alamoudi W; Moussa Z; Alim H; Safi F; Duggan J
Am J Med Sci; 2019 Jan; 357(1):67-74. PubMed ID: 30278875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
